The Brutalist Report

CNBC

• Alphabet calls out new AI-related risks, as it taps debt market to fund buildout [96d]
• Tulsi Gabbard to testify at Senate Intelligence Committee amid election probe concerns [96d]
• Housing affordability package set to advance in Congress amid home-cost concerns [96d]
• Morgan Stanley says buy 2 beaten-down software stocks. We agree on one of them [96d]
• Target steps up investment in store staffing, cuts about 500 other roles to help fix customer experience [96d]
• Our basket of stocks that benefit from higher spending on AI is up again [96d]
• Under the hood of the AI economy with Databricks CEO Ali Ghodsi [96d]
• What's driving Procter & Gamble's monster start to 2026 — and how it can continue [96d]
• Student loan complaints hit record high, CFPB finds — but the watchdog agency omits details [96d]
• FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims [96d]
• This ancillary AI stock hits another record high. How we're playing the rally [96d]
• Following Super Bowl ad, Trump accounts launch a new sign-up option [96d]
• Short-seller CapitalWatch apologizes, retracts report on AppLovin shareholder [96d]
• Monday.com drops 19% as AI disruption fears mount in software [96d]
• Some student loan borrowers wait over a year in public servant debt forgiveness backlog [96d]
• Databricks completes $5 billion funding round at $134 billion valuation [96d]
• Workday CEO Carl Eschenbach is stepping down, co-founder Aneel Bhusri to take over [96d]
• How to read people and master your body language to be more influential at work [96d]
• Hamptons real estate prices hit record, with 2026 summer rentals going fast [97d]
• Meta starts big week in court, with opening arguments beginning in New Mexico, LA trials [97d]
• Sam Altman touts ChatGPT's reaccelerating growth to employees as OpenAI closes in on $100 billion funding [97d]
• Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections [97d]